- Home
- FFAI vs IOBT Comparison
FFAI vs IOBT Comparison
Compare FFAI & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFAI
- IOBT
- Stock Information
- Founded
- FFAI 2014
- IOBT 2014
- Country
- FFAI United States
- IOBT Denmark
- Employees
- FFAI N/A
- IOBT N/A
- Industry
- FFAI
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- FFAI
- IOBT Health Care
- Exchange
- FFAI NYSE
- IOBT Nasdaq
- Market Cap
- FFAI 111.5M
- IOBT 91.6M
- IPO Year
- FFAI N/A
- IOBT 2021
- Fundamental
- Price
- FFAI $2.05
- IOBT $1.79
- Analyst Decision
- FFAI
- IOBT Strong Buy
- Analyst Count
- FFAI 0
- IOBT 3
- Target Price
- FFAI N/A
- IOBT $9.33
- AVG Volume (30 Days)
- FFAI 12.0M
- IOBT 231.3K
- Earning Date
- FFAI 08-13-2025
- IOBT 08-12-2025
- Dividend Yield
- FFAI N/A
- IOBT N/A
- EPS Growth
- FFAI N/A
- IOBT N/A
- EPS
- FFAI N/A
- IOBT N/A
- Revenue
- FFAI $853,000.00
- IOBT N/A
- Revenue This Year
- FFAI $115,335.99
- IOBT N/A
- Revenue Next Year
- FFAI N/A
- IOBT N/A
- P/E Ratio
- FFAI N/A
- IOBT N/A
- Revenue Growth
- FFAI 8.52
- IOBT N/A
- 52 Week Low
- FFAI $0.83
- IOBT $0.66
- 52 Week High
- FFAI $21.89
- IOBT $1.90
- Technical
- Relative Strength Index (RSI)
- FFAI N/A
- IOBT 68.80
- Support Level
- FFAI N/A
- IOBT $1.34
- Resistance Level
- FFAI N/A
- IOBT $1.74
- Average True Range (ATR)
- FFAI 0.00
- IOBT 0.11
- MACD
- FFAI 0.00
- IOBT 0.02
- Stochastic Oscillator
- FFAI 0.00
- IOBT 93.18
About FFAI FARADAY FUTURE INTELLIGENT ELEC INC
Faraday Future Intelligent Electric Inc is a shared intelligent mobility ecosystem. The company is poised to break the boundaries between the Internet, IT, creative, and auto industries with product and service offerings that integrate new energy, AI, Internet, and sharing models. The company has additional engineering, sales, and operational capabilities in China and plans to develop its manufacturing capability in China through a joint venture.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.